Mátyás, C., & Szabó, G. (2017). Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes. European journal of heart failure, 19(3), . https://doi.org/10.1002/ejhf.711
Chicago Style (17th ed.) CitationMátyás, Csaba, and Gábor Szabó. "Prevention of the Development of Heart Failure with Preserved Ejection Fraction by the Phosphodiesterase-5A Inhibitor Vardenafil in Rats with Type 2 Diabetes." European Journal of Heart Failure 19, no. 3 (2017). https://doi.org/10.1002/ejhf.711.
MLA (9th ed.) CitationMátyás, Csaba, and Gábor Szabó. "Prevention of the Development of Heart Failure with Preserved Ejection Fraction by the Phosphodiesterase-5A Inhibitor Vardenafil in Rats with Type 2 Diabetes." European Journal of Heart Failure, vol. 19, no. 3, 2017, https://doi.org/10.1002/ejhf.711.